Clin2
NCT07569328Possibly a fitNot yet recruiting

Low-dose colchicine after heart bypass surgery

CAD - Coronary Artery DiseaseCABGColchicine

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests whether taking a low dose of colchicine, an anti-inflammatory medicine, after heart bypass surgery can help keep the new blood vessels open and working well. It may help reduce the chance of the bypass grafts failing.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
622 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must be within 3 days of having coronary artery bypass surgery (CABG).
  • You must not need additional heart valve surgery.
  • You must not have had cancer (other than skin cancer) in the last 3 years.
  • You must not have inflammatory bowel disease or chronic diarrhea.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06215989Recruiting
Low-dose colchicine for acute coronary syndrome

This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.

Beijing, Beijing Municipality
NCT06802926Recruiting· Phase 4
Colchicine to prevent graft failure after bypass surgery

This study tests whether a low dose of colchicine, an anti-inflammatory drug, can help prevent the graft (new blood vessel) from failing after heart bypass surgery. It's for people who just had a bypass and are still in the hospital.

Shanghai
NCT07287345Recruiting· Phase 4
Colchicine’s effect on inflammation after heart bypass surgery

This trial tests whether the drug colchicine can reduce inflammation after planned coronary artery bypass graft (CABG) surgery. It may help patients recover better by lowering inflammatory markers.

Lexington, Kentucky
NCT07411768Not yet recruiting
Low-dose colchicine to prevent blood clots after heart valve replacement

This study tests whether a low dose of the medicine colchicine can help prevent blood clots after a TAVR procedure, which replaces a narrowed heart valve. If you've recently had TAVR, taking colchicine might lower your risk of clots.

Beijing
NCT07611019Enrolling by invitation· Phase 2/Phase 3
Colchicine to prevent heart rhythm problems after heart bypass surgery

This study tests whether taking colchicine (a common anti-inflammatory medication) before and after bypass heart surgery can prevent atrial fibrillation—an irregular heartbeat that sometimes occurs after surgery. Researchers hope this simple treatment might reduce complications and improve recovery.

Taipei
NCT05618353Recruiting· Phase 4
Colchicine before surgery to lower heart and inflammation complications

This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.

Birmingham, Alabama

Hear when a new CABG trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.